MainStay Diversified Income A
MainStay Funds 169 Lackawanna Ave. Parsippany, NJ 07054
Map
Phone: 800-624-6782
| Category: | Multisector Bond | | Fund Family: | MainStay | | Net Assets: | 69.18M | | Year-to-Date Return: | 1.73% | | Yield: | 4.89% | | Morningstar Rating: |  | | Fund Inception Date: | 28-Feb-97 |
|
Dan Roberts
Lead Manager since
30-Oct-09 | | | Roberts joined MacKay Shields in 2004 when the firm acquired the fixed income division of Pareto Partners. He was the chief investment officer and an equity shareholder at Pareto. Roberts assembled the US fixed income team while serving 10 years at UBS Asset Management, most recently as managing director and head of the fixed income group. Prior to its acquisition by UBS, he was a financial economist for Chase Manhattan Bank, NA and later was head of Global Interest Rate and Currency Swaps Trading. |
| Min Initial Investment: | $25,000 | | Min Initial Investment, IRA: | $1,000 | | Min Initial Investment, AIP: | $500 | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | $50 | | Min Subsequent Investment, AIP: | $50 |
|
| |
| The investment seeks current income and competitive overall return. The fund normally invests at least 65% of assets in U.S. and foreign debt or debt-related securities. It allocates assets among various bond market sectors: U.S. government debt, foreign government debt, and U.S. and foreign corporate debt. The fund may invest up to 30% of assets in equities, including common and preferred stocks, rights, and warrants. It may also invest in emerging-market securities. |
| Last Dividend
(29-Jan-10):
| 0.06 | | Last Cap Gain
(21-Dec-99):
| 0.03 | | Annual Holdings Turnover
| 154.00% | | Average for Category:
| 114.05% |
|
| Expense | MASAX | Category
Avg | | Total Expense Ratio: | 1.19%
| 1.17% | | Max 12b1 Fee: | 0.25%
| N/A | | Max Front End Sales Load: | 4.50%
| 4.18% | | Max Deferred Sales Load: | %
| 2.51% | | 3 Yr Expense Projection*: |
$ 841 | $526 | | 5 Yr Expense Projection*: |
$ 1,137 | $822 | | 10 Yr Expense Projection*: |
$ 1,978 | $1,643 |
|
|
0.10% Nasdaq 
Profile
